EU approves Covid-19 drug remdesivir

Portfolio
The first drug to treat severe cases of Covid-19 in the European Union has been given the green light, with the European Commission approving remdesivir on Friday.
gilead

It is the first time the EU's executive arm has granted the approval to a Covid-19 drug and was the last step for remdesivir to be given the full the go-ahead.

Remdesivir, manufactured by U.S. biotech company Gilead Sciences, was originally developed as an Ebola treatment.

This decision follows a recommendation from the European Medicines Agency (EMA), which last week said that the drug - sold under the name Veklury - should be approved for treating Covid-19 patients over the age of 12 who require supplemental oxygen.

An international study at the end of April with over 1,000 participants showed that remdesivir could reduce the time needed for Covid-19 patients to recover from 15 to 11 days on average.

Friday's approval comes shortly after the U.S. government had announced an agreement with Gilead Sciences, according to which it bought up almost all of the drug supplies for the upcoming months. On Thursday, the European Commission said it was also in talks with the company to secure sufficient doses for the EU.

We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus,

Stella Kyriakides, the EU's health commissioner, said in a statement.

Cover photo: David Paul Morris/Bloomberg via Getty Images

More in Business

bpairport
August 12, 2020 11:22

Budapest airport handles 300,000 passengers in July

Still an 80% decrease yr/yr but four times the June number

otp
August 12, 2020 08:44

Hungary’s OTP buys 45,000 treasury shares

Programme spending nearly HUF 65 bn this year

raiffeisen bank_getty
August 11, 2020 09:27

Raiffeisen posts EUR 192 mn Q2 profit

ROE target for 2020 lowered to 5%

otp
August 07, 2020 11:55

Hungary’s OTP posts strong Q2 results

Bank appears to be crisis-resistant

August 07, 2020 10:11

Hungary’s OTP buys 110,000 treasury shares

Programme spending nearly HUF 63 bn this year

Megvan az MFB új vezérigazgatója
August 06, 2020 16:42

Hungarian Development Bank H1 profit jumps

No profit expected in 2020